For the sake of clarity, we speak of anergic cells within clones, rather than anergic clones, since apparently anergic clones also comprise a minority of CLL cells that are potentially capable of proliferating following BcR engagement, as already discussed. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.